HOLX vs RVPH · P/E 32, rev $4.10B vs $7.6M cap
Hologic Inc (HOLX) versus Reviva Pharmaceuticals Holdings Inc. (RVPH) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Reviva Pharmaceuticals Holdings Inc. (RVPH) is a biotechnology company listed on NASDAQ.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
RVPH does not have a complete income-statement cache yet.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. RVPH currently screens at market cap $7.6M.
Not investment advice. Open the HOLX and RVPH stock pages for the full models.
Not investment advice.